THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Sarah Little to Maternal Serum Screening Tests

This is a "connection" page, showing publications Sarah Little has written about Maternal Serum Screening Tests.
Connection Strength

0.797
  1. The influence of noninvasive prenatal testing on gestational age at time of abortion for aneuploidy. Prenat Diagn. 2017 Jul; 37(7):635-639.
    View in: PubMed
    Score: 0.579
  2. When ultrasound anomalies are present: An estimation of the frequency of chromosome abnormalities not detected by cell-free DNA aneuploidy screens. Prenat Diagn. 2018 03; 38(4):250-257.
    View in: PubMed
    Score: 0.152
  3. Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA). Prenat Diagn. 2016 May; 36(5):456-62.
    View in: PubMed
    Score: 0.033
  4. What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy? Prenat Diagn. 2016 Mar; 36(3):260-5.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES